These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33824469)

  • 1. Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras.
    Lao Q; Merke DP
    Eur J Hum Genet; 2021 Jul; 29(7):1047-1048. PubMed ID: 33824469
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; New MI
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):699-718. PubMed ID: 19944288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
    Kim YM; Lee BH; Choi JH; Kim GH; Lim HH; Yoo HW
    Gene; 2013 Sep; 527(1):394-6. PubMed ID: 23769969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple virilising congenital adrenal hyperplasia in monozygotic twins: A rare report and review of previous cases.
    Muthuvel B; Gautam A; Pal R; Panigrahi I; Dayal D
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):58-62. PubMed ID: 32272826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.
    Concolino P; Costella A
    Mol Diagn Ther; 2018 Jun; 22(3):261-280. PubMed ID: 29450859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments to “A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency”.
    Concolino P; Mello E; Rossodivita A; Giardina B; Capoluongo E
    Gene; 2014 Jan; 534(2):449-450. PubMed ID: 24501745
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments to "a rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency".
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2014 Jan; 534(2):451-2. PubMed ID: 24100083
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA typing of patients with 21-hydroxylase deficiency in Iranian children with congenital adrenal hyperplasia.
    Haghi Ashtiani MT; Rabbani A; Mostafavi F; Monajemzadeh M; Ranjbar Kermani F; Soltaninia J
    Biochem Genet; 2008 Dec; 46(11-12):712-9. PubMed ID: 18777204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Parsa AA; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):2-11. PubMed ID: 27380651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.
    Chen W; Perritt AF; Morissette R; Dreiling JL; Bohn MF; Mallappa A; Xu Z; Quezado M; Merke DP
    Hum Mutat; 2016 Sep; 37(9):893-7. PubMed ID: 27297501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment.
    Nimkarn S; New MI
    Ann N Y Acad Sci; 2010 Mar; 1192():5-11. PubMed ID: 20392211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Common mutations of congenital adrenal hyperplasia are also the hotspots for new mutations].
    Zhang Q; Li W; Li S; Tang W; Li L; Lu G
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):669-72. PubMed ID: 22588921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation.
    Narasimhan ML; Khattab A
    Fertil Steril; 2019 Jan; 111(1):24-29. PubMed ID: 30611409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis].
    Ramos I; Regadera A; Román P; Ezquieta B
    Med Clin (Barc); 2008 Nov; 131(16):638-9. PubMed ID: 19080859
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
    Speiser PW
    Endocrinol Metab Clin North Am; 2001 Mar; 30(1):31-59, vi. PubMed ID: 11344938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
    Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Approaches to the Diagnosis of Classical form of Congenital Adrenal Hyperplasia.
    Przybylik-Mazurek E; Kurzynska A; Skalniak A; Hubalewska-Dydejczyk A
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):103-10. PubMed ID: 26434610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital adrenal hyperplasia: an update in children.
    Trapp CM; Speiser PW; Oberfield SE
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):166-70. PubMed ID: 21494138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.